Reportlinker Adds Medical Imaging Technologies for Oncology Diagnostics: The Global Market
NEW YORK, May 3, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Medical Imaging Technologies for Oncology Diagnostics: The Global Market
Review technologies such as computed tomography (CT), dual-slice and multi-slice tomography, positron emission tomography (PET), positron emission mammography (PEM), digital X-rays, single photon emission computed tomography (SPECT), full-body MRIs, gamma cameras, and 2-D and 3-D ultrasounds
Provide global market data for 2002, 2006, and 2008, with estimates for 2009, and compound annual growth rate (CAGR) projections through 2014
Discuss market drivers for earlier cancer detection and increasing trends of preventive medicine throughout the world
Offer a comprehensive list of company profiles.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
The goal of this study is to report on the size of the global and regional markets for imaging equipment used in the diagnosis of cancer. This includes the markets of 2009 and 2010 and the trends and sales in these markets for 2010 through 2015. Important manufacturers, technologies and factors influencing demand are discussed, including reasons behind the market forecasts, drivers and restraints in each market segment, and current and expected environmental influences on these markets.
The reader of this study will gain a solid overall look at the current market for diagnostic imaging equipment in oncology, and the elements expected to drive the markets during the next 5 years. The reader will be better equipped to create a company strategy that will positively affect business activities and revenue during the next 5 years.
REASONS FOR DOING THE STUDY
Developments in diagnostic imaging are radically changing oncology diagnostic procedures. Due to the breadth and scope of these developments, there are significant opportunities for companies to both design and market new products, and to profitably partner with companies offering complementary equipment. This study discusses where such opportunities lie today, and in what directions future prospects may lie.
SCOPE OF REPORT
Oncology diagnostic imaging products designate hardware, software, and supplies used to create, view, and manage visual images of nonvisible organs of the human body for purposes of diagnosing cancer. The report focuses on end-user markets, including hospitals, freestanding clinics, doctors' offices, and equipment leasing companies.
The following well-established technologies are included in the study: flat panel display (FPD) products such as computed radiography (CR), x-ray, including analog and digital x-ray; magnetic resonance imaging (MRI), including standard MRI and functional MRI or MR fluoroscopy; computed tomography (CT), including standard CT, multislice or ultrafast CT, and electron beam tomography; single photon emission computed tomography (SPECT); positron emission tomography (PET); ultrasound; and endoscopy, including fiber-optic endoscopy, video endoscopy, and ingestible cameras. In the last few years, several multimodal products have been developed in an attempt to combine the advantages of structural and functional imaging. Multimodal combinations currently on the market include CT/SPECT; PET/CT; MRI/MSI; and endoscopic ultrasound (EUS), combining fiber-optic endoscopy and ultrasound. Nearly 100% of all PET sales today are in the form of combination PET/CT imaging systems; therefore, this report addresses the market for PET/CT oncology diagnostics systems rather than PET standalone systems.
New and emerging technologies that may become commercially significant by 2015 are also addressed in this report. These include contrast-enhanced ultrasound, subharmonic breast ultrasound, whole-breast ultrasound tomography, radiation luminescence and radioactive optical nano-imaging techniques, near-infrared fluorescent imaging, near-infrared (NIR) optical coherence tomography, supersonic shear imaging (SSI), microwave tomography, cone beam CT, digital breast tomosynthesis (DBT), single-shot spectral imaging (SSSI) for mammography, breast-specific gamma imaging (BSGI), and photoacoustic tomography (PT). The latest development in combination imaging is PET/MR, now being introduced by Siemens, Philips, and GE.
Products used for radiotherapy, dentistry, nonmedical imaging (e.g., in physics, chemistry, geology, and industry), and veterinary medicine are excluded from the study.
INTENDED AUDIENCE
This report is intended for industry managers of business development, marketing and engineering; CEOs; venture capital companies; and research and development companies and executives.
METHODOLOGY AND INFORMATION SOURCES
Both primary and secondary research methodologies were used in preparing this report. Information was acquired from interviews with industry managers and physicians. Information also came from extensive secondary research in medical journals, newsletters, manufacturers' websites, published news items, and research reports on the Internet.
CHAPTER ONE: INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
METHODOLOGY AND INFORMATION SOURCES
ANALYST CREDENTIALS
RELATED REPORTS
BCC ONLINE SERVICES
DISCLAIMER
CHAPTER TWO: SUMMARY
SUMMARY TABLE GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, 2009-2015 ($ MILLIONS)
CHAPTER THREE: OVERVIEW
DEFINITION OF THE INDUSTRY
HISTORY AND CURRENT STATE OF MEDICAL IMAGING
DESCRIPTION OF THE MAJOR PRODUCTS AND TECHNOLOGIES
DIGITAL RADIOGRAPHY
Computed Radiography
Fluoroscopy
Endoscopy
PACS
Magnetic Resonance Imaging (MRI)
Ultrasound
Computed Tomography (CT)
PET
SPECT
TYPES OF APPLICATIONS: DIAGNOSIS
TYPES OF ANALYSIS: STRUCTURAL AND FUNCTIONAL
IMPROVEMENTS IN QUALITY, EFFECTIVENESS, AND SAFETY
EPIDEMIOLOGY OF COMMON CANCERS
TABLE 1 GLOBAL CANCER INCIDENCE AND PREVALENCE
TABLE 2 MANUFACTURERS OF X-RAY SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)
TABLE 3 MANUFACTURERS OF CT SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)
TABLE 4 MANUFACTURERS OF MRI SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)
TABLE 5 MANUFACTURERS OF ULTRASOUND SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)
TABLE 6 MANUFACTURERS OF ENDOSCOPY SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)
TABLE 7 MANUFACTURERS OF PACS SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)
TABLE 8 MANUFACTURERS OF SPECT SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)
TABLE 9 MANUFACTURERS OF PET/CT SYSTEMS MARKET SHARE (DOLLAR SALES), 2009 (%)
TABLE 10 NUMBER OF INSTALLED SELECT DIAGNOSTIC IMAGING UNITS, BY LOCATION, 2009
TABLE 11 NUMBER OF DIAGNOSTIC RADIOLOGY PROFESSIONALS, BY LOCATION, 2009
Price-Per-Imaging Study
TABLE 12 PRICE PER STUDY IN U.S., BY PROCEDURE TYPE, THROUGH 2015 ($)
Hospital Expenditure on Diagnostic Imaging Equipment, U.S.
TABLE 13 HOSPITAL EXPENDITURES ON DIAGNOSTIC IMAGING EQUIPMENT, BY TECHNOLOGY TYPE (U.S.), THROUGH 2015 ($ MILLIONS)
CHAPTER FOUR: DIAGNOSTIC IMAGING PATENTS
TABLE 14 RECENT U.S. PATENTS FOR DIAGNOSTIC IMAGING
TABLE 15 RECENT PATENT AND PATENT APPLICATIONS FOR DIAGNOSTIC IMAGING
CHAPTER FIVE: GOVERNMENT REGULATION
U.S. FOOD AND DRUG ADMINISTRATION
U.S. STATE REGULATIONS
DEFICIT REDUCTION ACT
U.S. CENTERS FOR MEDICARE AND MEDICAID SERVICES
TABLE 16 CMS ACTIONS REGARDING DIAGNOSTIC IMAGING, 2003-2011
NATIONAL COVERAGE DETERMINATIONS FOR FDG-PET
REIMBURSEMENT PUSHED FOR VIRTUAL COLONOSCOPY (VC)
MEDICARE INDICATIONS FOR PET AND PET/CT
TABLE 17 MEDICARE COVERAGE OF FDG-PET AND PET/CT
Clarification of Asterisked Portions of Table 17
WILL CT SCREENING FOR LUNG CANCER BE COVERED NEXT?
FOREIGN GOVERNMENT AGENCIES
UNITED KINGDOM'S NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
EUROPEAN UNION AND THE CE MARK
INVESTMENT BY THE EIB
JAPAN
CHAPTER SIX: INDUSTRY STRUCTURE
INTRODUCTION
MAJOR MARKETS
TRENDS IN PRICE AND PRICE/PERFORMANCE
OTHER FACTORS INFLUENCING DEMAND
CLINICAL GUIDELINES ISSUED BY PROFESSIONAL GROUPS AND INSURER
DEMOGRAPHIC CHANGES
MARKET SATURATION
GENERAL TECHNOLOGY ISSUES
IMAGE RESOLUTION AND UNIFORMITY
FIELD OF VIEW—SIZE AND VARIABILITY
SPEED OF IMAGE ACQUISITION AND GENERATION
RADIATION DOSE
REACTION TO CONTRAST MEDIA
PATIENT COMFORT: EXAM TIME, NOISE, AND LARGER BORE SIZE
EASE AND RELIABILITY OF OPERATION
OPEN DATA COMMUNICATION STANDARDS (DICOM)
NEW TECHNOLOGY BY TECHNOLOGY TYPE
MRI
ULTRASOUND
ENDOSCOPY
COMPUTED TOMOGRAPHY
NUCLEAR IMAGING
HEALTHCARE IT
MARKETS BY APPLICATION
TABLE 18 ONCOLOGY DIAGNOSTIC IMAGING MARKETS, BY APPLICATION, 2009 ($ MILLIONS/%)
FIGURE 1 ONCOLOGY DIAGNOSTIC IMAGING MARKETS, BY APPLICATION, 2009 (%)
SUMMARY
CHAPTER SEVEN: MARKETS BY PRODUCTS
MARKETS BY PRODUCTS
TABLE 19 PERCENTAGE USE IN ONCOLOGY DIAGNOSTICS APPLIED TO EACH MODALITY, 2009 (%)
TABLE 20 GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
TABLE 21 GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 (UNITS)
TABLE 22 DIAGNOSTIC IMAGING FOR ONCOLOGY: USER EXPENDITURES, BY GEOGRAPHY, THROUGH 2015 ($ MILLIONS/%)
THE U.S. MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 23 U.S. MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
THE CANADA-MEXICO-BRAZIL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 24 CANADA, MEXICO, BRAZIL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
CANADA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 25 CANADA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
MEXICO MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 26 MEXICO MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
BRAZIL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 27 BRAZIL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
THE EU MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 28 EU MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
UNITED KINGDOM MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 29 UNITED KINGDOM MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
GERMANY MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 30 GERMANY MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
FRANCE MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 31 FRANCE MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
SPAIN MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 32 SPAIN MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
ITALY MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 33 ITALY MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
REST OF EUROPE MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 34 REST OF EUROPE MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
THE JAPAN MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 35 JAPAN MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
THE CHINA-INDIA-AUSTRALIA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 36 CHINA, INDIA, AUSTRALIA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
CHINA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 37 CHINA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
INDIA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 38 INDIA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
AUSTRALIA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 39 AUSTRALIA MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
OTHER MARKETS FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY
TABLE 40 OTHER MARKETS FOR DIAGNOSTIC IMAGING EQUIPMENT FOR ONCOLOGY, BY SEGMENT, THROUGH 2015 ($ MILLIONS)
MARKET DRIVERS AND RESTRAINTS
TABLE 41 DRIVERS AND RESTRAINTS AFFECTING MARKETS FOR DIAGNOSTIC IMAGING EQUIPMENT
STRATEGIES FOR VENDORS TO SUCCEED
CHAPTER EIGHT: COMPANIES
AGFA HEALTHCARE
CANON
ESAOTE S.P.A.
FUJIFILM MEDICAL SYSTEMS
GE HEALTHCARE
GIVEN IMAGING
HITACHI MEDICAL SYSTEMS AMERICA, INC.
HOLOGIC
IMAGING DYNAMICS COMPANY (IDC)
IMAGING DIAGNOSTIC SYSTEMS, INC. (IDSI)
IMIX AMERICAS, INC.
KONICA MINOLTA MEDICAL IMAGING
MAUNA KEA TECHNOLOGIES
MCKESSON CORPORATION
MINDRAY
OLYMPUS
PHILIPS HEALTHCARE
PLANMED OY
SHIMADZU CORPORATION
SIEMENS HEALTHCARE
SONOSITE, INC.
SUPERSONIC IMAGINE SA
TECHNISCAN MEDICAL SYSTEMS
TOSHIBA MEDICAL SYSTEMS
ULTRASONIX MEDICAL
VIZTEK LLC
APPENDIX: COMPANY LISTING
3DISC AMERICAS
ADVANCED MEDICAL DIAGNOSTICS, SA
AGFA HEALTHCARE NV
AGFA HEALTHCARE
ALLPRO IMAGING
ALOKA AMERICA
ALOKA TOKYO HEADQUARTERS
APELEM
ATYS MEDICAL
AURORA IMAGING TECHNOLOGY
BIOSOUND ESAOTE, INC.
CANON MEDICAL SYSTEMS, INC.
CARESTREAM HEALTH, INC
CARESTREAM HEALTH SA
COCIR BRUSSELS OFFICE
DILON DIAGNOSTICS
DXRAD
EDGE MEDICAL DEVICES INC.
EDGE MEDICAL DEVICES, LTD.
ENVISIONEERING MEDICAL TECHNOLOGIES
ESAOTE GROUP
FONAR CORPORATION
FUJIFILM MEDICAL SYSTEMS
FUJINON, INC.
GE HEALTHCARE
GE HEALTHCARE
GIVEN IMAGING, LTD.
GROUPE DMS
GYRUS ACMI - SURGICAL AND ENDOSCOPY
HOLOGIC, INC.
IMAGING3, INC.
IMAGING DIAGNOSTIC SYSTEMS INC.
IMIX AMERICAS, INC.
I.M.S.
KONICA MINOLTA HOLDINGS, INC.
KONICA MINOLTA U.S.
MAUNA KEA TECHNOLOGIES
MCKESSON CORPORATION
MINDRAY MEDICAL
MINDRAY NORTH AMERICA U.S., CANADA & LATIN AMERICA
NAVISCAN INC.
NOVARAD
ONCONCEPTS, LLC
PHILIPS HEALTHCARE
PHILIPS HEALTHCARE
RF CO., LTD.
RIVERAIN MEDICAL
SIEMENS MEDICAL SOLUTIONS USA, INC
SPECTRASCIENCE, INC.
SUPERSONIC IMAGINE SA
TECHNISCAN MEDICAL SYSTEMS, INC.
TOSHIBA AMERICA MEDICAL SYSTEMS
TOSHIBA MEDICAL VISUALIZATION SYSTEMS EUROPE, LTD.
ULTRASONIX MEDICAL CORP.
VIRTUAL IMAGING, INC.
VIZTEK, LLC
ZIOSOFT INC.
ZIOSOFT INC.
More Details
To order this report:
: Medical Imaging Technologies for Oncology Diagnostics: The Global Market
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-6
SOURCE Reportlinker
Share this article